Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 4:31 pm Sale |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 3,561,337 4.000% |
-699,704 (-16.42%) |
Filing History |
| 2024-01-22 4:15 pm Sale |
2023-12-31 | 13G | Twist Bioscience Corporation TWST |
Integrated Core Strategies (US) LLC | 1,821,238 3.200% |
-1,224,675 (-40.21%) |
Filing History |
| 2024-01-22 4:10 pm Sale |
2023-12-31 | 13G | SI-BONE, Inc. SIBN |
Integrated Core Strategies (US) LLC | 1,210,324 3.000% |
-1,066,163 (-46.83%) |
Filing History |
| 2024-01-22 4:07 pm Purchase |
2023-12-31 | 13G | Embecta Corp. EMBC |
Integrated Core Strategies (US) LLC | 3,635,948 6.300% |
467,043 (+14.74%) |
Filing History |
| 2024-01-19 4:32 pm Sale |
2023-12-31 | 13G | ZimVie Inc. ZIMV |
Integrated Core Strategies (US) LLC | 714,592 2.700% |
-763,832 (-51.67%) |
Filing History |
| 2024-01-19 4:19 pm Purchase |
2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Integrated Core Strategies (US) LLC | 25,465 0.200% |
25,465 (New Position) |
Filing History |
| 2024-01-18 4:40 pm Purchase |
2024-01-08 | 13G | NETSTREIT Corp. NTST |
Integrated Core Strategies (US) LLC | 3,903,441 5.700% |
3,468,171 (+796.79%) |
Filing History |
| 2024-01-17 4:54 pm Purchase |
2024-01-10 | 13G | Sutro Biopharma, Inc. STRO |
Integrated Core Strategies (US) LLC | 3,451,825 5.700% |
3,451,825 (New Position) |
Filing History |
| 2024-01-10 4:22 pm Purchase |
2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Integrated Core Strategies (US) LLC | 1,418,675 5.700% |
56,576 (+4.15%) |
Filing History |
| 2024-01-08 4:32 pm Sale |
2023-12-31 | 13G | Avid Bioservices, Inc. CDMO |
Integrated Core Strategies (US) LLC | 4,240,147 6.700% |
-354,880 (-7.72%) |
Filing History |
| 2023-12-19 4:05 pm Purchase |
2023-12-12 | 13G | Avid Bioservices, Inc. CDMO |
Integrated Core Strategies (US) LLC | 4,595,027 7.300% |
3,943,316 (+605.07%) |
Filing History |
| 2023-12-04 4:09 pm Purchase |
2023-11-27 | 13G | Abeona Therapeutics Inc. ABEO |
Integrated Core Strategies (US) LLC | 1,362,099 5.500% |
1,362,099 (New Position) |
Filing History |
| 2023-11-17 4:05 pm Purchase |
2023-11-08 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,770,894 5.600% |
5,770,894 (New Position) |
Filing History |
| 2023-10-17 4:14 pm Purchase |
2023-10-10 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 4,261,041 5.200% |
4,261,041 (New Position) |
Filing History |
| 2023-09-26 4:26 pm Purchase |
2023-09-18 | 13G | BioLife Solutions, Inc. BLFS |
Integrated Core Strategies (US) LLC | 2,481,946 5.700% |
2,481,946 (New Position) |
Filing History |
| 2023-09-13 4:29 pm Purchase |
2023-09-06 | 13G | Embecta Corp. EMBC |
Integrated Core Strategies (US) LLC | 3,168,905 5.500% |
3,168,905 (New Position) |
Filing History |
| 2023-09-08 4:43 pm Purchase |
2023-09-01 | 13G | Twist Bioscience Corporation TWST |
Integrated Core Strategies (US) LLC | 3,045,913 5.300% |
3,045,913 (New Position) |
Filing History |
| 2023-07-17 4:50 pm Purchase |
2023-07-12 | 13G | Freeline Therapeutics Holdings plc FRLN |
Integrated Core Strategies (US) LLC | 5,555,085 8.500% |
5,555,085 (New Position) |
Filing History |
| 2023-06-08 4:30 pm Purchase |
2023-06-06 | 13G | Elevation Oncology, Inc. ELEV |
Integrated Core Strategies (US) LLC | 1,397,382 5.700% |
1,397,382 (New Position) |
Filing History |
| 2023-05-11 4:57 pm Purchase |
2023-05-05 | 13G | SI-BONE, Inc. SIBN |
Integrated Core Strategies (US) LLC | 2,276,487 5.900% |
1,490,024 (+189.46%) |
Filing History |